GRAIL Poaches New CEO From Roche, Genentech Post author:Sam Post published:December 13, 2017 Post category:BioPharma Four months after Jeff Huber stepped down as CEO of GRAIL, the company has tapped his replacement. Source: BioSpace You Might Also Like Genentech Dumps Another $650M in New Haven Biotech Arvinas November 14, 2017 Groundbreaking: Amicus Surges as the FDA Changes Its Tune on Fabry Disease Drug July 10, 2017 Amgen on a Roll as the FDA OKs Repatha to Prevent Heart Attack and Stroke December 3, 2017